IRIS
ANNESE, VITO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.648
NA - Nord America 3.559
EU - Europa 2.721
SA - Sud America 1.069
AF - Africa 86
OC - Oceania 8
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.093
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.372
SG - Singapore 2.963
CN - Cina 1.266
BR - Brasile 920
HK - Hong Kong 855
CZ - Repubblica Ceca 826
IT - Italia 618
RO - Romania 267
VN - Vietnam 226
DE - Germania 217
GB - Regno Unito 158
RU - Federazione Russa 130
CA - Canada 107
IN - India 89
SE - Svezia 84
FI - Finlandia 77
NL - Olanda 66
AT - Austria 63
AR - Argentina 60
MX - Messico 60
PL - Polonia 58
ZA - Sudafrica 49
JP - Giappone 48
BD - Bangladesh 44
ES - Italia 41
LT - Lituania 31
TR - Turchia 28
FR - Francia 26
IQ - Iraq 23
EC - Ecuador 22
VE - Venezuela 20
CO - Colombia 18
UA - Ucraina 17
ID - Indonesia 15
PY - Paraguay 13
MA - Marocco 12
AE - Emirati Arabi Uniti 11
PK - Pakistan 9
SA - Arabia Saudita 9
UZ - Uzbekistan 9
AZ - Azerbaigian 7
BE - Belgio 7
TN - Tunisia 6
CH - Svizzera 5
CL - Cile 5
JM - Giamaica 5
PE - Perù 5
TW - Taiwan 5
UY - Uruguay 5
AL - Albania 4
BY - Bielorussia 4
EG - Egitto 4
GR - Grecia 4
JO - Giordania 4
MY - Malesia 4
NP - Nepal 4
AU - Australia 3
BH - Bahrain 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HN - Honduras 3
IL - Israele 3
IR - Iran 3
KE - Kenya 3
KZ - Kazakistan 3
MD - Moldavia 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
GA - Gabon 2
GE - Georgia 2
IE - Irlanda 2
KG - Kirghizistan 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
PS - Palestinian Territory 2
PW - Palau 2
RS - Serbia 2
SN - Senegal 2
TH - Thailandia 2
AM - Armenia 1
AQ - Antartide 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
KI - Kiribati 1
KR - Corea 1
KW - Kuwait 1
LB - Libano 1
LY - Libia 1
NG - Nigeria 1
NO - Norvegia 1
Totale 13.087
Salva come PNG Salva come JPEG
Città #
Singapore 1.812
Dallas 1.555
Hong Kong 847
Olomouc 826
Ashburn 382
Hefei 350
Shanghai 327
Beijing 187
New York 171
Milan 161
Los Angeles 114
Munich 90
São Paulo 88
Ho Chi Minh City 71
Hanoi 60
Rome 54
Warsaw 51
Nuremberg 48
Montreal 44
Moscow 43
Brooklyn 42
Denver 40
Tokyo 38
Helsinki 37
Boardman 35
London 35
Chennai 34
Johannesburg 32
Poplar 32
Santa Clara 31
Turku 30
Amsterdam 28
Stockholm 28
Toronto 28
Chicago 27
Orem 26
Vienna 26
Atlanta 25
Boston 25
Lawrence 24
Mexico City 23
Princeton 23
Turin 23
Falkenstein 22
Assago 20
Manchester 20
Phoenix 20
The Dalles 20
Ankara 19
Belo Horizonte 19
Washington 19
Brasília 18
Frankfurt am Main 18
San Jose 18
Seattle 17
San Francisco 16
Bologna 15
Guarulhos 15
Rio de Janeiro 15
Brescia 14
Campinas 13
Houston 13
Mumbai 13
Porto Alegre 13
Catania 12
Charlotte 12
Curitiba 12
Figino 12
Miami 12
Dhaka 11
Guangzhou 11
Guayaquil 11
Naples 11
Florence 10
Genoa 10
Haiphong 10
New Delhi 10
Council Bluffs 9
Hangzhou 9
Biên Hòa 8
Ottawa 8
Tashkent 8
Tianjin 8
Baku 7
Buffalo 7
Cape Town 7
Columbus 7
Lucknow 7
Paris 7
Querétaro 7
Thái Bình 7
Vancouver 7
Asunción 6
Baghdad 6
Brussels 6
City of London 6
Cotia 6
Goiânia 6
Juneau 6
Lappeenranta 6
Totale 8.635
Salva come PNG Salva come JPEG
Nome #
10-year follow-up results of the European Achalasia Trial: a multicentre randomised controlled trial comparing pneumatic dilation with laparoscopic Heller myotomy 1.350
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy 130
Corrigendum: Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial 125
Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial 125
Crohn's Colitis: Development of a multiplex gene expression assay comparing mRNA levels of susceptibility genes 124
Comparative efficacy of first-line therapeutic interventions for achalasia: a systematic review and network meta-analysis 122
Authors' answers on comment of Abellona et al. on Metabolomic analysis for noninvasive diagnosis of hepatic fibrosis degree in patients with chronic hepatitis C 113
An update on treatment of ulcerative colitis 113
Biosimilars in IBD: Similarity Breeds Contented Patients 109
Correction to: Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management 108
IBD and malignancies: The gender matters 107
First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus 107
Global variability of the human IgG glycome 107
Percutaneous ultrasound-guided fiducial marker placement for liver cancer robotic stereotactic radio-surgery treatment: A comparative analysis of three types of markers and needles 95
Association between polymorphisms in antioxidant genes and inflammatory bowel disease 89
Italian consensus conference for colonic diverticulosis and diverticular disease 88
Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole 87
Long-term results of the European Achalasia trial: A multicentre randomised Controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy 76
Erratum: Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 (Nature Genetics (2011) 43 (246-252)) 69
A PROLONGED FOLLOW-UP ON THE EFFICACY AND SAFETY OF INFLIXIMAB BIOSIMILAR CT-P13 IN IBD ACROSS ITALY: THE PROSIT COHORT 69
The Endoscopic Management of Zenker’s Diverticulum: A Comprehensive Review 68
Fundoplication: Old Concept for Novel Challenges? 67
Ambulatory oesophageal pH-metry: Position paper of the working team on oesophageal pH-metry by the GISMAD (Gruppo Italiano di Studio sulla Motilita dell'Apparato Digerente) 67
Bloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation-predominant irritable bowel syndrome and functional constipation 66
A multicenter randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group 64
Prospective Evaluation of Liver Stiffness Using Transient Elastography in Alcoholic Patients following Abstinence 61
VAC-Stent in the Treatment of Post-Esophagectomy Anastomotic Leaks: A New “Kid on the Block” Who Marries the Best of Old Techniques—A Review 60
The role of glycosylation in IBD 59
The Endoscopic Management of Anastomotic Strictures After Esophagogastric Surgery: A Comprehensive Review of Emerging Approaches Beyond Endoscopic Dilation 59
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment 58
Ustekinumab as induction and maintenance therapy for Crohn's disease 58
Dual-channel endoscope for double-traction endoscopic device-assisted full-thickness resection of rectal superficial tumor 57
Prediction of Crohn's Disease by profiles of single nucleotide polymorphisms 56
"Appropriateness" or "prioritization" for GI endoscopic procedures? 55
A further "stri(v)de" in IBD management 54
Unraveling the pathogenesis of Barrett’s esophagus and esophageal adenocarcinoma: the “omics” era 54
ABO blood groups and cancer of the pancreas 54
Results of the 4th Scientific Workshop of the ECCO (Group II): Markers of intestinal fibrosis in inflammatory bowel disease 53
European evidence based consensus for endoscopy in inflammatory bowel disease 53
Pre- and post-procedural quality indicators for colonoscopy: A nationwide survey 53
A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis 53
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes 52
3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 1: Diagnosis and medical management 51
Acute respiratory distress in the adult during Gram-negative-induced sepsis. Clinical contribution 51
Biosimilars in Italy: a gastroenterologist's view 50
Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis 50
Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease 50
Erratum: Genome-wide association identifies multiple ulcerative colitis susceptibility loci 50
Maintenance treatment with azathioprine in ulcerative colitis: Outcome and predictive factors after drug withdrawal 50
Risk factor analysis for therapy related adverse events and infections in elder patients with Inflammatory Bowel Disease; An analysis from the IG-IBD aged study 49
Erratum: Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study(Nature Genetics (2009) 41 (216220)) 49
Vitamin D regulates the tight-junction protein expression in active ulcerative colitis 48
Composition of the gut microbiota in patients with inflammatory bowel disease in Saudi Arabia: A pilot stud 47
Genome-wide association identifies multiple ulcerative colitis susceptibility loci 47
Allele-specific transcriptional activity of the variable number of tandem repeats of the inducible nitric oxide synthase gene is associated with idiopathic achalasia 47
Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: Clinical role and review of the literature 47
Endoscopic Management of Post-Esophagectomy Delayed Gastric Conduit Emptying (DGCE): Results from a Cohort Study in a Tertiary Referral Center with Comparison between Procedures 47
13C-octanoic acid breath test for measuring gastric emptying of solids 46
Gastrointestinal motility disorders in inflammatory bowel diseases 46
The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease 46
Subgroups of patients with Crohn's disease have different clinical outcomes 46
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease 46
Aberrant DNA methylation in non-neoplastic gastric mucosa of H. pylori infected patients and effect of eradication 45
Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: Comparison of different assays and correlation with clinical features 45
Adalimumab in active ulcerative colitis: A "real-life" observational study 45
A normal gastrointestinal motility excludes chronic intestinal pseudoobstruction in children 44
Randomised controlled trial of mesalazine in IBS 44
Clinical features and HLA association of 5-aminosalicylate (5-ASA)-induced nephrotoxicity in inflammatory bowel disease 43
HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder 43
The PROSIT-BIO Cohort of the IG-IBD: A Prospective Observational Study of Patients With Inflammatory Bowel Disease Treated With Infliximab BioSimilars 43
Precision Medicine in Inflammatory Bowel Disease 43
Advances in Endo-Hepatology: The Role of Endoscopic Ultrasound in the Management of Portal Hypertension 42
Attributes of intestinal microbiota composition and their correlation with clinical primary non-response to anti-TNF-α agents in inflammatory bowel disease patients 42
Gastrointestinal motility disorders in patients with inactive Crohn's disease 42
Roundtable on biosimilars with European regulators and medical societies, Brussels, Belgium, 12 January 2016 42
Azathioprine for prevention of clinical recurrence in Crohn's disease patients with severe endoscopic recurrence: an IG-IBD randomized double-blind trial 42
Acute intestinal obstruction and NOD2/CARD15 mutations among italian Crohn's disease patients 42
Esophageal manometry. Normalcy and pathology 42
Osteoarticular manifestations during liver and gastrointestinal diseases 42
Oral prolonged release beclomethasone dipropionate and prednisone in the treatment of active ulcerative colitis: Results from a double-blind, randomized, parallel group study 42
Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management 42
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 42
Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use 42
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 41
Genetics and epigenetics of IBD 41
Clinical features in familial cases of Crohn's disease and ulcerative colitis in Italy: A GISC study 41
CARD15 gene variants and risk of reoperation in crohn's disease patients 41
Fatal ulcerative panenteritis following colectomy in a patient with ulcerative colitis 41
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases 41
Association of Crohn's disease and ulcerative colitis with haplotypes of the MLH1 gene in Italian inflammatory bowel disease patients [2] 40
Genetics of Inflammatory Bowel Disease 39
Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia 39
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications 39
Beclomethasone dipropionate for the treatment of ulcerative colitis 39
Association of ankylosing spondylitis with hairy cell leukemia: A previously once reported case 39
Risk Factor Analysis for Therapy Related Adverse Events and Infections in Elder Patients With Inflammatory Bowel Disease; An Analysis From the iG-IBD Aged Study 39
Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study 39
Ustekinumab: Moving the target from psoriasis to Crohn's disease 39
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment 38
Polymorphism of motilin gene in patients with Crohn's disease 38
Totale 7.130
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.875
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.875
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 1 0 0 0 0 0
2021/202230 0 0 0 27 0 0 0 0 0 1 0 2
2022/2023118 60 26 1 1 2 15 2 3 8 0 0 0
2023/20241.240 93 8 31 57 13 60 5 25 5 9 496 438
2024/20254.250 254 33 44 205 295 402 833 262 539 577 344 462
2025/20267.905 1.174 1.309 1.445 1.826 1.655 496 0 0 0 0 0 0
Totale 13.545